[1]JACOBSE JN,STEGGINK LC,SONKE GS,et al.Myocardial dysfunction in long-term breast cancer survivors treated at ages 40~50 years [J].Eur J Heart Fail,2020,22(2):338-346.
[2]FELKER GM,THOMPSON RE,HARE JM,et al.Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy [J].New England Journal of Medicine,2000,342(15):1077-1084.
[3]PLANA JC,GALDERISI M,BARAC A,et al.Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy:a report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging [J].Eur Heart J Cardiovasc Imaging,2014,15(10):1063-1093.
[4]THAVENDIRANATHAN P,RANKIN K.3-dimensional echocardiography:Moving from pretty pictures toward patient outcomes [J].JACC Cardiovasc Imaging,2019,12(10):1927-1929.
[5]MITCHELL C,RAHKO PS,BLAUWET LA,et al.Guidelines for performing a comprehensive transthoracic echocardiographic examination in adults:Recommendations from the American society of echocardiography [J].J Am Soc Echocardiogr,2019,32(1):1-64.
[6]CHARBONNEL C,CONVERS-DOMART R,RIGAUDEAU S,et al.Assessment of global longitudinal strain at low-dose anthracycline-based chemotherapy,for the prediction of subsequent cardiotoxicity [J].Eur Heart J Cardiovasc Imaging,2017,18(4):392-401.
[7]THAVENDIRANATHAN P,GRANT AD,NEGISHI T,et al.Reproducibility of echocardiographic techniques for sequential assessment of left ventricular ejection fraction and volumes [J].Journal of the American College of Cardiology,2013,61(1):77-84.
[8]LAMBERT J,LAMACIE M,THAMPINATHAN B,et al.Variability in echocardiography and MRI for detection of cancer therapy cardiotoxicity [J].Heart,2020,106(11):817-823.
[9]SANTORO C,ARPINO G,ESPOSITO R,et al.2D and 3D strain for detection of subclinical anthracycline cardiotoxicity in breast cancer patients:a balance with feasibility [J].European Heart Journal-Cardiovascular Imaging,2017,18(8):930-936.
[10]ZAMORANO JL,LANCELLOTTI P,RODRIGUEZ MUOZ D,et al.2016 ESC position paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC committee for practice guidelines:The task force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology(ESC) [J].Eur J Heart Fail,2017,19(1):9-42.
[11]于海如,于韬.医学影像技术在蒽环类药物致心脏毒性反应中的应用与评价[J].现代肿瘤医学,2018,26(24):4042-4045.
YU Hairu,YU Tao.Evaluation and application of medical imaging technology in cardiac toxicity induced by anthracycline [J].Modern Oncology,2018,26(24):4042-4045.
[12]DORUP I,LEVITT G,SULLIVAN I,et al.Prospective longitudinal assessment of late anthracycline cardiotoxicity after childhood cancer:the role of diastolic function [J].Heart,2004,90(10):1214-1216.
[13]谭娅,胡波,冷倩倩,等.二维斑点追踪分层应变技术评价蒽环类药物化疗患者早期心肌毒性[J].临床超声医学杂志,2019,21(3):166-172.
TAN Y,HU B,LENG QQ,et al.Early evaluation of cardiotoxicity by two-dimensional speckle tracking layer-specific imaging in patients with anthracycline chemotherapy [J].Journal of Clinical Ultrasound in Medicine,2019,21(3):166-172.
[14]何璇,赵晓莉,王少春,等.斑点追踪分层应变技术评价蒽环类化疗药物对乳腺癌患者左室心肌纵向应变的影响[J].临床超声医学杂志,2018,20(6):397-400.
HE X,ZHAO XL,WANG SC,et al.Evaluation on the effect of anthracycline-induced cardiotoxity on left ventricular myocardial strain by speckle tracking layered strain technique in breast cancer patients [J].Journal of Clinical Ultrasound in Medicine,2018,20(6):397-400.
[15]BERGAMINI C,DOLCI G,TRUONG S,et al.Role of speckle tracking echocardiography in the evaluation of breast cancer patients undergoing chemotherapy:Review and Meta-analysis of the literature [J].Cardiovasc Toxicol,2019,19(6):485-492.
[16]GALDERISI M,ESPOSITO R,SCHIANO-LOMORIELLO V,et al.Correlates of global area strain in native hypertensive patients:a three-dimensional speckle-tracking echocardiography study [J].Eur Heart J Cardiovasc Imaging,2012,13(9):730-738.
[17]MIYOSHI T,TANAKA H,KANEKO A,et al.Left ventricular endocardial dysfunction in patients with preserved ejection fraction after receiving anthracycline [J].Echocardiography,2014,31(7):848-857.